nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Skin necrosis—Methotrexate—multiple sclerosis	0.00647	0.0226	CcSEcCtD
Terlipressin—Bradycardia—Fingolimod—multiple sclerosis	0.00622	0.0217	CcSEcCtD
Terlipressin—Cardiac disorder—Fingolimod—multiple sclerosis	0.00567	0.0198	CcSEcCtD
Terlipressin—Angiopathy—Fingolimod—multiple sclerosis	0.00555	0.0194	CcSEcCtD
Terlipressin—Atrial fibrillation—Cladribine—multiple sclerosis	0.00529	0.0185	CcSEcCtD
Terlipressin—Cardiac failure—Cladribine—multiple sclerosis	0.00513	0.0179	CcSEcCtD
Terlipressin—Hypertension—Fingolimod—multiple sclerosis	0.00459	0.016	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.0045	0.0157	CcSEcCtD
Terlipressin—Nervous system disorder—Fingolimod—multiple sclerosis	0.00426	0.0149	CcSEcCtD
Terlipressin—Skin disorder—Fingolimod—multiple sclerosis	0.00422	0.0147	CcSEcCtD
Terlipressin—Dyspnoea—Fingolimod—multiple sclerosis	0.00387	0.0135	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00375	0.0131	CcSEcCtD
Terlipressin—Cardiac failure—Mitoxantrone—multiple sclerosis	0.00337	0.0118	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisolone—multiple sclerosis	0.00331	0.0116	CcSEcCtD
Terlipressin—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00331	0.0115	CcSEcCtD
Terlipressin—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00327	0.0114	CcSEcCtD
Terlipressin—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.00326	0.0114	CcSEcCtD
Terlipressin—Cardiac disorder—Cladribine—multiple sclerosis	0.00322	0.0112	CcSEcCtD
Terlipressin—Cyanosis—Methotrexate—multiple sclerosis	0.00319	0.0111	CcSEcCtD
Terlipressin—Angiopathy—Cladribine—multiple sclerosis	0.00314	0.011	CcSEcCtD
Terlipressin—Pulmonary oedema—Triamcinolone—multiple sclerosis	0.00305	0.0106	CcSEcCtD
Terlipressin—Pulmonary oedema—Methylprednisolone—multiple sclerosis	0.00304	0.0106	CcSEcCtD
Terlipressin—Malnutrition—Cladribine—multiple sclerosis	0.00302	0.0105	CcSEcCtD
Terlipressin—Diarrhoea—Fingolimod—multiple sclerosis	0.00297	0.0104	CcSEcCtD
Terlipressin—Skin exfoliation—Dexamethasone—multiple sclerosis	0.00296	0.0103	CcSEcCtD
Terlipressin—Skin exfoliation—Betamethasone—multiple sclerosis	0.00296	0.0103	CcSEcCtD
Terlipressin—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.00276	0.00965	CcSEcCtD
Terlipressin—Pulmonary oedema—Betamethasone—multiple sclerosis	0.00276	0.00965	CcSEcCtD
Terlipressin—Headache—Fingolimod—multiple sclerosis	0.00272	0.0095	CcSEcCtD
Terlipressin—Skin exfoliation—Prednisone—multiple sclerosis	0.00258	0.00901	CcSEcCtD
Terlipressin—Chest pain—Cladribine—multiple sclerosis	0.00257	0.00897	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00255	0.0089	CcSEcCtD
Terlipressin—Cardiac failure—Methylprednisolone—multiple sclerosis	0.00254	0.00887	CcSEcCtD
Terlipressin—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.0025	0.00873	CcSEcCtD
Terlipressin—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00249	0.00868	CcSEcCtD
Terlipressin—Nervous system disorder—Cladribine—multiple sclerosis	0.00241	0.00843	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisone—multiple sclerosis	0.00241	0.0084	CcSEcCtD
Terlipressin—Tachycardia—Cladribine—multiple sclerosis	0.0024	0.00839	CcSEcCtD
Terlipressin—Skin disorder—Cladribine—multiple sclerosis	0.00239	0.00835	CcSEcCtD
Terlipressin—Bradycardia—Mitoxantrone—multiple sclerosis	0.00232	0.00809	CcSEcCtD
Terlipressin—Cardiac failure—Dexamethasone—multiple sclerosis	0.00231	0.00806	CcSEcCtD
Terlipressin—Cardiac failure—Betamethasone—multiple sclerosis	0.00231	0.00806	CcSEcCtD
Terlipressin—Respiratory failure—Methotrexate—multiple sclerosis	0.0023	0.00803	CcSEcCtD
Terlipressin—Dyspnoea—Cladribine—multiple sclerosis	0.0022	0.00766	CcSEcCtD
Terlipressin—Skin exfoliation—Methotrexate—multiple sclerosis	0.00216	0.00753	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00213	0.00742	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00207	0.00724	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00205	0.00716	CcSEcCtD
Terlipressin—Myocardial infarction—Prednisolone—multiple sclerosis	0.00204	0.00712	CcSEcCtD
Terlipressin—Pulmonary oedema—Methotrexate—multiple sclerosis	0.00201	0.00702	CcSEcCtD
Terlipressin—Cardiac failure—Prednisone—multiple sclerosis	0.00201	0.00702	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—LINGO1—multiple sclerosis	0.00198	0.00278	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00198	0.00277	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00196	0.00275	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL10—multiple sclerosis	0.00196	0.00274	CbGpPWpGaD
Terlipressin—Abdominal pain—Cladribine—multiple sclerosis	0.00195	0.00679	CcSEcCtD
Terlipressin—Skin disorder—Azathioprine—multiple sclerosis	0.00194	0.00679	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00194	0.00272	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00193	0.0027	CbGpPWpGaD
Terlipressin—Bradycardia—Prednisolone—multiple sclerosis	0.0019	0.00664	CcSEcCtD
Terlipressin—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00189	0.00659	CcSEcCtD
Terlipressin—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00188	0.00657	CcSEcCtD
Terlipressin—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00188	0.00655	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL13—multiple sclerosis	0.00187	0.00263	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCR1—multiple sclerosis	0.00187	0.00263	CbGpPWpGaD
Terlipressin—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00187	0.00654	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00187	0.00262	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00181	0.00253	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCL3—multiple sclerosis	0.0018	0.00253	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL3—multiple sclerosis	0.00179	0.00251	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00178	0.00249	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00177	0.00248	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—S1PR1—multiple sclerosis	0.00176	0.00247	CbGpPWpGaD
Terlipressin—Bradycardia—Triamcinolone—multiple sclerosis	0.00175	0.00611	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00175	0.00245	CbGpPWpGaD
Terlipressin—Bradycardia—Methylprednisolone—multiple sclerosis	0.00175	0.00609	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.00174	0.00243	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00173	0.00603	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00172	0.00242	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TAGAP—multiple sclerosis	0.00172	0.00241	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00171	0.00598	CcSEcCtD
Terlipressin—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00171	0.00598	CcSEcCtD
Terlipressin—Hypertension—Mitoxantrone—multiple sclerosis	0.00171	0.00598	CcSEcCtD
Terlipressin—Myocardial infarction—Dexamethasone—multiple sclerosis	0.0017	0.00594	CcSEcCtD
Terlipressin—Myocardial infarction—Betamethasone—multiple sclerosis	0.0017	0.00594	CcSEcCtD
Terlipressin—Chest pain—Mitoxantrone—multiple sclerosis	0.00169	0.00589	CcSEcCtD
Terlipressin—Diarrhoea—Cladribine—multiple sclerosis	0.00168	0.00588	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCL5—multiple sclerosis	0.00168	0.00236	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.00168	0.00235	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCR3—multiple sclerosis	0.00166	0.00233	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.00165	0.00231	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00164	0.0023	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCR2—multiple sclerosis	0.00163	0.00229	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCR2—multiple sclerosis	0.00162	0.00227	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00161	0.00226	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00161	0.00225	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.0016	0.00224	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.0016	0.00224	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.0016	0.00224	CbGpPWpGaD
Terlipressin—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00159	0.00556	CcSEcCtD
Terlipressin—Bradycardia—Dexamethasone—multiple sclerosis	0.00159	0.00554	CcSEcCtD
Terlipressin—Bradycardia—Betamethasone—multiple sclerosis	0.00159	0.00554	CcSEcCtD
Terlipressin—Abdominal pain—Azathioprine—multiple sclerosis	0.00158	0.00552	CcSEcCtD
Terlipressin—Tachycardia—Mitoxantrone—multiple sclerosis	0.00158	0.00551	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00157	0.00221	CbGpPWpGaD
Terlipressin—Skin disorder—Mitoxantrone—multiple sclerosis	0.00157	0.00549	CcSEcCtD
Terlipressin—Vomiting—Cladribine—multiple sclerosis	0.00157	0.00546	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.00156	0.00219	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00156	0.00219	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00156	0.00218	CbGpPWpGaD
Terlipressin—Angiopathy—Methylprednisolone—multiple sclerosis	0.00156	0.00543	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00155	0.00218	CbGpPWpGaD
Terlipressin—Headache—Cladribine—multiple sclerosis	0.00154	0.00538	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00153	0.00215	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00152	0.00213	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00152	0.00213	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCR5—multiple sclerosis	0.00152	0.00213	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CNR1—multiple sclerosis	0.00151	0.00211	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—S1PR1—multiple sclerosis	0.0015	0.0021	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—RGS1—multiple sclerosis	0.0015	0.0021	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CNR1—multiple sclerosis	0.00149	0.00209	CbGpPWpGaD
Terlipressin—Malnutrition—Methylprednisolone—multiple sclerosis	0.00149	0.00521	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00149	0.00521	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—RGS1—multiple sclerosis	0.00149	0.00208	CbGpPWpGaD
Terlipressin—Myocardial infarction—Prednisone—multiple sclerosis	0.00148	0.00518	CcSEcCtD
Terlipressin—Nausea—Cladribine—multiple sclerosis	0.00146	0.0051	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—GPC5—multiple sclerosis	0.00146	0.00205	CbGpPWpGaD
Terlipressin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00144	0.00504	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.00143	0.002	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00143	0.002	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—GPR65—multiple sclerosis	0.00142	0.00199	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR1—multiple sclerosis	0.00142	0.00199	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00142	0.00199	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00142	0.00198	CbGpPWpGaD
Terlipressin—Angiopathy—Betamethasone—multiple sclerosis	0.00141	0.00494	CcSEcCtD
Terlipressin—Angiopathy—Dexamethasone—multiple sclerosis	0.00141	0.00494	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—GPR65—multiple sclerosis	0.00141	0.00198	CbGpPWpGaD
Terlipressin—Hypertension—Prednisolone—multiple sclerosis	0.0014	0.0049	CcSEcCtD
Terlipressin—Bradycardia—Prednisone—multiple sclerosis	0.00138	0.00483	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00138	0.00193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LINGO1—multiple sclerosis	0.00137	0.00193	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00137	0.00192	CbGpPWpGaD
Terlipressin—Diarrhoea—Azathioprine—multiple sclerosis	0.00137	0.00478	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00137	0.00192	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LINGO1—multiple sclerosis	0.00136	0.00191	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.00136	0.0019	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00135	0.00189	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL3—multiple sclerosis	0.00134	0.00187	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.00133	0.00186	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.0013	0.00182	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR1—multiple sclerosis	0.0013	0.00182	CbGpPWpGaD
Terlipressin—Tachycardia—Prednisolone—multiple sclerosis	0.0013	0.00452	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00129	0.00181	CbGpPWpGaD
Terlipressin—Hypertension—Triamcinolone—multiple sclerosis	0.00129	0.00451	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CCR1—multiple sclerosis	0.00129	0.00181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00129	0.00181	CbGpPWpGaD
Terlipressin—Hypertension—Methylprednisolone—multiple sclerosis	0.00129	0.0045	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.00129	0.0018	CbGpPWpGaD
Terlipressin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00128	0.00447	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—RGS1—multiple sclerosis	0.00128	0.00179	CbGpPWpGaD
Terlipressin—Vomiting—Azathioprine—multiple sclerosis	0.00127	0.00444	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00126	0.00441	CcSEcCtD
Terlipressin—Headache—Azathioprine—multiple sclerosis	0.00125	0.00438	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CXCR3—multiple sclerosis	0.00124	0.00174	CbGpPWpGaD
Terlipressin—Angiopathy—Prednisone—multiple sclerosis	0.00123	0.0043	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CNR1—multiple sclerosis	0.00123	0.00172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GPR65—multiple sclerosis	0.00121	0.0017	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCR2—multiple sclerosis	0.00121	0.00169	CbGpPWpGaD
Terlipressin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00119	0.00417	CcSEcCtD
Terlipressin—Tachycardia—Triamcinolone—multiple sclerosis	0.00119	0.00416	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—TAGAP—multiple sclerosis	0.00119	0.00167	CbGpPWpGaD
Terlipressin—Nausea—Azathioprine—multiple sclerosis	0.00119	0.00415	CcSEcCtD
Terlipressin—Tachycardia—Methylprednisolone—multiple sclerosis	0.00119	0.00415	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00119	0.00167	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—POMC—multiple sclerosis	0.00119	0.00166	CbGpPWpGaD
Terlipressin—Skin disorder—Methylprednisolone—multiple sclerosis	0.00118	0.00413	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—TAGAP—multiple sclerosis	0.00118	0.00166	CbGpPWpGaD
Terlipressin—Malnutrition—Prednisone—multiple sclerosis	0.00118	0.00413	CcSEcCtD
Terlipressin—Hypertension—Betamethasone—multiple sclerosis	0.00117	0.00409	CcSEcCtD
Terlipressin—Hypertension—Dexamethasone—multiple sclerosis	0.00117	0.00409	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCL5—multiple sclerosis	0.00117	0.00164	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCL2—multiple sclerosis	0.00116	0.00163	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL5—multiple sclerosis	0.00116	0.00162	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CNR1—multiple sclerosis	0.00111	0.00156	CbGpPWpGaD
Terlipressin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00111	0.00387	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CXCL13—multiple sclerosis	0.00111	0.00155	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR1—multiple sclerosis	0.00111	0.00155	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00111	0.00155	CbGpPWpGaD
Terlipressin—Dyspnoea—Triamcinolone—multiple sclerosis	0.00109	0.0038	CcSEcCtD
Terlipressin—Nervous system disorder—Betamethasone—multiple sclerosis	0.00109	0.00379	CcSEcCtD
Terlipressin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00109	0.00379	CcSEcCtD
Terlipressin—Tachycardia—Dexamethasone—multiple sclerosis	0.00108	0.00377	CcSEcCtD
Terlipressin—Tachycardia—Betamethasone—multiple sclerosis	0.00108	0.00377	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00108	0.00151	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00107	0.0015	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00106	0.00148	CbGpPWpGaD
Terlipressin—Cardiac disorder—Methotrexate—multiple sclerosis	0.00105	0.00368	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCR5—multiple sclerosis	0.00105	0.00147	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00105	0.00147	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCR5—multiple sclerosis	0.00104	0.00146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—S1PR1—multiple sclerosis	0.00104	0.00146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—S1PR1—multiple sclerosis	0.00103	0.00145	CbGpPWpGaD
Terlipressin—Angiopathy—Methotrexate—multiple sclerosis	0.00103	0.00359	CcSEcCtD
Terlipressin—Vomiting—Mitoxantrone—multiple sclerosis	0.00103	0.00359	CcSEcCtD
Terlipressin—Hypertension—Prednisone—multiple sclerosis	0.00102	0.00356	CcSEcCtD
Terlipressin—Headache—Mitoxantrone—multiple sclerosis	0.00101	0.00354	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—GPC5—multiple sclerosis	0.00101	0.00142	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GPC5—multiple sclerosis	0.00101	0.00141	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL10—multiple sclerosis	0.001	0.00141	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.001	0.00349	CcSEcCtD
Terlipressin—Malnutrition—Methotrexate—multiple sclerosis	0.000988	0.00345	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000981	0.00138	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000974	0.00137	CbGpPWpGaD
Terlipressin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000963	0.00336	CcSEcCtD
Terlipressin—Nausea—Mitoxantrone—multiple sclerosis	0.000961	0.00336	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000957	0.00334	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000957	0.00334	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000951	0.00133	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000948	0.00133	CbGpPWpGaD
Terlipressin—Nervous system disorder—Prednisone—multiple sclerosis	0.000946	0.0033	CcSEcCtD
Terlipressin—Tachycardia—Prednisone—multiple sclerosis	0.000942	0.00329	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000941	0.00132	CbGpPWpGaD
Terlipressin—Skin disorder—Prednisone—multiple sclerosis	0.000937	0.00327	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000926	0.0013	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000922	0.00129	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL3—multiple sclerosis	0.000919	0.00129	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000915	0.00128	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000913	0.00128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000891	0.00125	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RGS1—multiple sclerosis	0.000885	0.00124	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000885	0.00124	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RGS1—multiple sclerosis	0.000879	0.00123	CbGpPWpGaD
Terlipressin—Abdominal pain—Betamethasone—multiple sclerosis	0.000876	0.00306	CcSEcCtD
Terlipressin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000876	0.00306	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CCL5—multiple sclerosis	0.000864	0.00121	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000861	0.00121	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000857	0.0012	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000854	0.0012	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000851	0.00119	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000845	0.00118	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000845	0.00118	CbGpPWpGaD
Terlipressin—Chest pain—Methotrexate—multiple sclerosis	0.000841	0.00294	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—GPR65—multiple sclerosis	0.000839	0.00118	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000837	0.00117	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000835	0.00292	CcSEcCtD
Terlipressin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000834	0.00291	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—GPR65—multiple sclerosis	0.000833	0.00117	CbGpPWpGaD
Terlipressin—Headache—Prednisolone—multiple sclerosis	0.000832	0.0029	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CCR2—multiple sclerosis	0.000831	0.00116	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000824	0.00115	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—POMC—multiple sclerosis	0.000822	0.00115	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—POMC—multiple sclerosis	0.000816	0.00114	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000804	0.00113	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL2—multiple sclerosis	0.000798	0.00112	CbGpPWpGaD
Terlipressin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000791	0.00276	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCL3—multiple sclerosis	0.000789	0.00111	CbGpPWpGaD
Terlipressin—Nausea—Prednisolone—multiple sclerosis	0.000789	0.00275	CcSEcCtD
Terlipressin—Skin disorder—Methotrexate—multiple sclerosis	0.000783	0.00273	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CCR5—multiple sclerosis	0.000778	0.00109	CbGpPWpGaD
Terlipressin—Vomiting—Triamcinolone—multiple sclerosis	0.000776	0.00271	CcSEcCtD
Terlipressin—Vomiting—Methylprednisolone—multiple sclerosis	0.000775	0.0027	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000773	0.00108	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR1—multiple sclerosis	0.000767	0.00108	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000767	0.00108	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000767	0.00107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CNR1—multiple sclerosis	0.000767	0.00107	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000766	0.00107	CbGpPWpGaD
Terlipressin—Headache—Triamcinolone—multiple sclerosis	0.000765	0.00267	CcSEcCtD
Terlipressin—Headache—Methylprednisolone—multiple sclerosis	0.000763	0.00266	CcSEcCtD
Terlipressin—Abdominal pain—Prednisone—multiple sclerosis	0.000763	0.00266	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CXCL13—multiple sclerosis	0.000762	0.00107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR1—multiple sclerosis	0.000762	0.00107	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00076	0.00107	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTGER4—multiple sclerosis	0.000759	0.00106	CbGpPWpGaD
Terlipressin—Diarrhoea—Betamethasone—multiple sclerosis	0.000758	0.00265	CcSEcCtD
Terlipressin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000758	0.00265	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—PGR—multiple sclerosis	0.000748	0.00105	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCR3—multiple sclerosis	0.000733	0.00103	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD28—multiple sclerosis	0.000727	0.00102	CbGpPWpGaD
Terlipressin—Nausea—Triamcinolone—multiple sclerosis	0.000725	0.00253	CcSEcCtD
Terlipressin—Nausea—Methylprednisolone—multiple sclerosis	0.000724	0.00253	CcSEcCtD
Terlipressin—Dyspnoea—Methotrexate—multiple sclerosis	0.000719	0.00251	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCR2—multiple sclerosis	0.000713	0.001	CbGpPWpGaD
Terlipressin—Vomiting—Dexamethasone—multiple sclerosis	0.000704	0.00246	CcSEcCtD
Terlipressin—Vomiting—Betamethasone—multiple sclerosis	0.000704	0.00246	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000696	0.00243	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000696	0.000975	CbGpPWpGaD
Terlipressin—Headache—Dexamethasone—multiple sclerosis	0.000694	0.00242	CcSEcCtD
Terlipressin—Headache—Betamethasone—multiple sclerosis	0.000694	0.00242	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000691	0.000968	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—POMC—multiple sclerosis	0.00067	0.000939	CbGpPWpGaD
Terlipressin—Diarrhoea—Prednisone—multiple sclerosis	0.00066	0.0023	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000659	0.000924	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CNR1—multiple sclerosis	0.000658	0.000923	CbGpPWpGaD
Terlipressin—Nausea—Betamethasone—multiple sclerosis	0.000658	0.0023	CcSEcCtD
Terlipressin—Nausea—Dexamethasone—multiple sclerosis	0.000658	0.0023	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000655	0.000917	CbGpPWpGaD
Terlipressin—Abdominal pain—Methotrexate—multiple sclerosis	0.000637	0.00222	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000633	0.000887	CbGpPWpGaD
Terlipressin—Vomiting—Prednisone—multiple sclerosis	0.000613	0.00214	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—POMC—multiple sclerosis	0.000608	0.000852	CbGpPWpGaD
Terlipressin—Headache—Prednisone—multiple sclerosis	0.000604	0.00211	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000599	0.000839	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL2—multiple sclerosis	0.000595	0.000834	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL5—multiple sclerosis	0.000594	0.000833	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000594	0.000833	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL10—multiple sclerosis	0.000593	0.000831	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.00059	0.000827	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000585	0.000821	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000581	0.000815	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000576	0.000807	CbGpPWpGaD
Terlipressin—Nausea—Prednisone—multiple sclerosis	0.000573	0.002	CcSEcCtD
Terlipressin—Diarrhoea—Methotrexate—multiple sclerosis	0.000552	0.00193	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CCL3—multiple sclerosis	0.000547	0.000766	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL3—multiple sclerosis	0.000543	0.000761	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—TYK2—multiple sclerosis	0.00054	0.000757	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR5—multiple sclerosis	0.000539	0.000756	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000536	0.000751	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000532	0.000745	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000528	0.00074	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000526	0.000738	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000523	0.000732	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PGR—multiple sclerosis	0.000518	0.000727	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD86—multiple sclerosis	0.000518	0.000727	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PGR—multiple sclerosis	0.000515	0.000721	CbGpPWpGaD
Terlipressin—Vomiting—Methotrexate—multiple sclerosis	0.000513	0.00179	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCL5—multiple sclerosis	0.00051	0.000715	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000508	0.000712	CbGpPWpGaD
Terlipressin—Headache—Methotrexate—multiple sclerosis	0.000505	0.00176	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CXCR3—multiple sclerosis	0.000505	0.000707	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD28—multiple sclerosis	0.000504	0.000706	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD28—multiple sclerosis	0.0005	0.000701	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—multiple sclerosis	0.000495	0.000694	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR2—multiple sclerosis	0.000495	0.000693	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR2—multiple sclerosis	0.000491	0.000688	CbGpPWpGaD
Terlipressin—Nausea—Methotrexate—multiple sclerosis	0.000479	0.00167	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—SPP1—multiple sclerosis	0.000473	0.000662	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—POMC—multiple sclerosis	0.000464	0.000651	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—POMC—multiple sclerosis	0.000461	0.000646	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR5—multiple sclerosis	0.00046	0.000644	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CNR1—multiple sclerosis	0.000456	0.00064	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2RA—multiple sclerosis	0.000453	0.000635	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CNR1—multiple sclerosis	0.000453	0.000635	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—multiple sclerosis	0.00045	0.00063	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—POMC—multiple sclerosis	0.000422	0.000591	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—POMC—multiple sclerosis	0.000419	0.000587	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOE—multiple sclerosis	0.000418	0.000586	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000413	0.000578	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000411	0.000576	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL2—multiple sclerosis	0.00041	0.000574	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000408	0.000572	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD80—multiple sclerosis	0.000378	0.00053	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000375	0.000525	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—TYK2—multiple sclerosis	0.000372	0.000521	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—POMC—multiple sclerosis	0.000359	0.000504	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD86—multiple sclerosis	0.000359	0.000504	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD86—multiple sclerosis	0.000357	0.0005	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL5—multiple sclerosis	0.000354	0.000496	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL2—multiple sclerosis	0.000352	0.000493	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL5—multiple sclerosis	0.000351	0.000492	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000344	0.000482	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—multiple sclerosis	0.000343	0.000481	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—multiple sclerosis	0.000341	0.000478	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SPP1—multiple sclerosis	0.000328	0.000459	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SPP1—multiple sclerosis	0.000325	0.000456	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TYK2—multiple sclerosis	0.000319	0.000447	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR5—multiple sclerosis	0.000319	0.000447	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR5—multiple sclerosis	0.000316	0.000443	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000314	0.00044	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2RA—multiple sclerosis	0.000312	0.000437	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—multiple sclerosis	0.000312	0.000437	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—multiple sclerosis	0.000309	0.000434	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOE—multiple sclerosis	0.00029	0.000406	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOE—multiple sclerosis	0.000288	0.000403	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—multiple sclerosis	0.000266	0.000372	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—multiple sclerosis	0.000264	0.00037	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD80—multiple sclerosis	0.000262	0.000367	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD80—multiple sclerosis	0.00026	0.000365	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—multiple sclerosis	0.000251	0.000352	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—POMC—multiple sclerosis	0.000249	0.000349	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—POMC—multiple sclerosis	0.000247	0.000347	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL2—multiple sclerosis	0.000244	0.000342	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL2—multiple sclerosis	0.000242	0.000339	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000238	0.000334	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000237	0.000332	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—multiple sclerosis	0.000224	0.000313	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TYK2—multiple sclerosis	0.000221	0.00031	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TYK2—multiple sclerosis	0.00022	0.000308	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—multiple sclerosis	0.000208	0.000291	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—multiple sclerosis	0.000207	0.00029	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK1—multiple sclerosis	0.000203	0.000285	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—multiple sclerosis	0.000184	0.000258	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—multiple sclerosis	0.000183	0.000257	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—multiple sclerosis	0.000183	0.000256	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—multiple sclerosis	0.000182	0.000255	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—multiple sclerosis	0.000174	0.000244	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—multiple sclerosis	0.000173	0.000242	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—multiple sclerosis	0.000156	0.000219	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—multiple sclerosis	0.000155	0.000217	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—multiple sclerosis	0.000154	0.000216	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—multiple sclerosis	0.000144	0.000202	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—multiple sclerosis	0.000144	0.000201	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—multiple sclerosis	0.000143	0.0002	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—multiple sclerosis	0.000143	0.0002	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK1—multiple sclerosis	0.000141	0.000197	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK1—multiple sclerosis	0.00014	0.000196	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—multiple sclerosis	0.000108	0.000152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—multiple sclerosis	0.000107	0.000151	CbGpPWpGaD
